DMRADamora Therapeutics, Inc.

$30.44

What is the market doing?

What the tape says about DMRA

Damora Therapeutics, Inc. is +834% over the past year while the S&P 500 is +23%: 811 points ahead of the market.

+834%

1-year return · S&P 500 +23%

vs 200-day average
+24%

vs 200-day average · a clear uptrend

RSI (14)
54

RSI (14) · neutral

Below its 52-week high
−11%

Below its 52-week high

2024-08-06$2.22 – $34.14 · dashed line: 200-day average2026-08-26
Details
Last close2026-08-26
$30.44
1 monthS&P 500 +3.7%
+4.2%
1 yearS&P 500 +23%
+834%
5 yearsS&P 500 +87%
−72%
vs 50-day average$27.20
+12%
52-week high
$34.14
52-week low
$2.58
Annualised volatility
343%
Calendar-year price return
YearReturn
2026 (year to date)+32%
2025+395%
2024−74%
2023−37%
2022−62%
2021−76%
Average return by calendar month, 2020–2026
MonthYearsPositiveAverage
Jan63 of 6+14%
Feb62 of 6−4.2%
Mar62 of 6−11%
Apr60 of 6−11%
May62 of 6−1.5%
Jun63 of 6+3.8%
Jul63 of 6+7.7%
Aug63 of 6−9.8%
Sep53 of 5+1.2%
Oct52 of 5+5.0%
Nov63 of 6+17%
Dec63 of 6−1.0%

End-of-day closes from IEX; the S&P 500 comparison uses SPY over the same window. Prices are a reference point, not a basis for trading decisions.